Profile data is unavailable for this security.
About the company
Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.
- Revenue in EUR (TTM)428.72m
- Net income in EUR-9.11m
- Incorporated1986
- Employees1.85k
- LocationIon Beam Applications SAChemin du Cyclotron 3LOUVAIN-LA-NEUVE 1348BelgiumBEL
- Phone+32 10475811
- Fax+32 10475810
- Websitehttps://iba-worldwide.com
Mergers & acquisitions
Acquired company | IBAB:BRU since announced | Transaction value |
---|---|---|
Radcal Corp | 32.05% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Detection Technology Oyj | -100.00bn | -100.00bn | 202.98m | 478.00 | -- | 2.79 | -- | -- | -- | -- | -- | 4.97 | -- | -- | -- | -- | -- | 9.34 | -- | 11.96 | -- | 47.44 | -- | 8.22 | 3.13 | -- | 0.081 | 53.45 | 5.29 | 2.02 | 7.55 | -18.03 | -14.88 | -9.55 |
Semperit Holding AG | 721.08m | 25.13m | 241.53m | 4.58k | 9.56 | 0.5679 | 3.87 | 0.335 | 1.23 | -0.8162 | 35.17 | 20.67 | 0.8098 | 4.68 | 8.24 | 157,578.90 | 2.79 | 5.25 | 3.60 | 7.32 | 22.46 | 24.79 | 3.45 | 5.59 | 1.38 | 4.92 | 0.3426 | 86.85 | -7.54 | -3.87 | -34.59 | -- | -7.21 | -- |
Tristel Plc | 46.14m | 7.05m | 258.03m | 213.00 | 37.01 | 7.08 | 25.81 | 5.59 | 0.1256 | 0.1256 | 0.8219 | 0.6567 | 0.992 | 1.51 | 6.26 | 185,394.40 | 15.17 | 8.86 | 17.10 | 10.24 | 82.59 | 80.63 | 15.29 | 10.63 | 3.93 | 411.73 | 0.1605 | 109.99 | 15.70 | 10.14 | 351.98 | 6.40 | 9.88 | 18.05 |
Nyxoah SA | 4.35m | -43.21m | 259.10m | 147.00 | -- | 2.64 | -- | 59.59 | -1.55 | -1.55 | 0.1555 | 3.42 | 0.0322 | 0.7891 | 2.06 | 29,618.53 | -31.98 | -23.73 | -35.88 | -25.98 | 61.91 | 62.42 | -993.86 | -1,469.59 | 4.50 | -- | 0.1147 | -- | 40.99 | -- | -38.39 | -- | 100.58 | -- |
BICO Group AB | 192.73m | -145.35m | 266.39m | 884.00 | -- | 0.6508 | -- | 1.38 | -23.61 | -27.66 | 31.60 | 69.18 | 0.2487 | 2.24 | 3.06 | 2,545,136.00 | -18.77 | -- | -20.89 | -- | 52.34 | -- | -75.47 | -- | 1.91 | -1.05 | 0.2852 | -- | 6.09 | -- | -1,889.33 | -- | -- | -- |
Medistim ASA | 44.78m | 8.83m | 282.36m | 152.00 | 31.89 | 8.32 | 26.04 | 6.31 | 5.68 | 5.68 | 28.77 | 21.77 | 1.07 | 0.8646 | 5.98 | 3,462,921.00 | 21.01 | 22.93 | 26.14 | 28.52 | 78.67 | 78.25 | 19.72 | 20.64 | 2.61 | -- | 0.0425 | 75.25 | 7.00 | 10.06 | -8.91 | 12.72 | 0.033 | 14.87 |
Lumibird SA | 203.56m | 7.13m | 313.41m | 1.05k | 39.20 | 1.62 | 12.81 | 1.54 | 0.3559 | 0.3559 | 9.14 | 8.62 | 0.5238 | 1.09 | 4.05 | 193,497.10 | 1.83 | 3.13 | 2.44 | 3.99 | 61.68 | 61.76 | 3.50 | 5.89 | 1.62 | 2.47 | 0.4287 | 0.00 | 6.60 | 15.12 | -37.23 | -2.47 | 18.34 | -- |
COLTENE Holding AG | 249.97m | 12.30m | 327.38m | 1.20k | 26.58 | 3.28 | 16.91 | 1.31 | 2.00 | 2.00 | 40.62 | 16.21 | 1.33 | 1.40 | 6.58 | 201,937.60 | 6.53 | 10.48 | 10.90 | 18.74 | 64.24 | 62.68 | 4.92 | 7.47 | 0.8045 | 5.62 | 0.3172 | 79.94 | -9.13 | 3.54 | -54.05 | -6.81 | -7.72 | -7.79 |
IVF Hartmann Holding AG | 152.36m | 15.60m | 338.60m | 304.00 | 21.71 | 2.17 | 15.91 | 2.22 | 6.31 | 6.31 | 61.63 | 63.07 | 0.8015 | 3.08 | 8.46 | 486,687.50 | 8.21 | 7.29 | 9.99 | 8.90 | 53.90 | 53.29 | 10.24 | 8.30 | 3.89 | -- | 0.0056 | 52.16 | -1.79 | 2.09 | 34.95 | 1.49 | -14.83 | 26.82 |
Ion Beam Applications SA | 428.72m | -9.11m | 400.94m | 1.85k | -- | 3.63 | 166.29 | 0.9352 | -0.313 | -0.313 | 14.73 | 3.65 | 0.702 | 2.54 | 2.73 | -- | -1.49 | 1.55 | -5.92 | 4.32 | 31.36 | 35.23 | -2.12 | 2.38 | 0.7103 | 0.9417 | 0.2814 | 43.06 | 18.67 | 10.74 | -250.40 | -- | -8.06 | -- |
Avon Protection PLC | 229.07m | -15.41m | 418.23m | 928.00 | -- | 2.86 | 101.17 | 1.83 | -0.4397 | -0.3861 | 6.54 | 4.13 | 0.7005 | 2.63 | 5.48 | 211,270.60 | -4.71 | -1.07 | -5.39 | -1.29 | 35.23 | 35.51 | -6.73 | -1.62 | 1.80 | 2.92 | 0.3822 | -- | -7.48 | 1.85 | -387.72 | -- | -1.66 | -7.86 |
Safilo Group SpA | 1.02bn | -24.65m | 446.04m | 3.83k | -- | 1.18 | 15.31 | 0.4353 | -0.0596 | -0.0596 | 2.48 | 0.9165 | 1.13 | 1.80 | 4.91 | 267,693.80 | -2.87 | -7.06 | -4.47 | -11.30 | 57.16 | 52.70 | -2.55 | -6.87 | 1.10 | 1.94 | 0.2848 | -- | -4.83 | 2.39 | -145.51 | -- | -15.50 | -- |
CellaVision AB | 58.02m | 11.16m | 449.50m | 228.00 | 40.27 | 7.32 | 30.85 | 7.75 | 5.46 | 5.46 | 28.40 | 30.04 | 0.7441 | 1.60 | 6.93 | 2,970,575.00 | 14.32 | 15.30 | 16.62 | 18.24 | 68.37 | 69.03 | 19.24 | 19.98 | 2.01 | 59.03 | 0.0828 | 110.18 | 5.94 | 13.17 | 10.12 | 8.00 | 30.45 | 8.45 |
Advanced Medical Solutions Group plc | 147.46m | 18.56m | 468.25m | 800.00 | 25.46 | 1.64 | 15.02 | 3.18 | 0.0724 | 0.0724 | 0.5755 | 1.12 | 0.4426 | 1.75 | 5.34 | -- | 5.57 | 6.54 | 6.04 | 7.06 | 55.57 | 56.75 | 12.59 | 14.82 | 4.00 | -- | 0.0361 | 25.83 | 1.51 | 4.23 | -22.14 | -6.71 | 15.66 | 12.32 |
Stratec SE | 261.91m | 13.07m | 486.92m | 1.52k | 37.26 | 2.09 | 15.83 | 1.86 | 1.07 | 1.07 | 21.54 | 19.19 | 0.6062 | 1.51 | 4.45 | 172,083.40 | 3.02 | 7.07 | 3.69 | 8.20 | 24.76 | 27.32 | 4.99 | 9.70 | 1.09 | 5.38 | 0.394 | 40.81 | -4.63 | 6.88 | -55.29 | 3.30 | -2.16 | -7.68 |
Holder | Shares | % Held |
---|---|---|
Premier Fund Managers Ltd.as of 30 Nov 2023 | 1.86m | 6.14% |
Belfius Insurance SA NVas of 31 Dec 2022 | 1.19m | 3.93% |
Van Lanschot Kempen Investment Management NVas of 31 Dec 2022 | 875.39k | 2.89% |
Paladin Asset Management Investmentaktiengesellschaft TGVas of 31 Dec 2022 | 768.77k | 2.54% |
BNP Paribas Asset Management Belgium SAas of 29 Feb 2024 | 552.43k | 1.82% |
NS PARTNERS EUROPE SAas of 01 Feb 2024 | 430.66k | 1.42% |
Investor Asset Management BVas of 05 Apr 2024 | 430.36k | 1.42% |
Fidelity Management & Research Co. LLCas of 29 Feb 2024 | 350.60k | 1.16% |
Norges Bank Investment Managementas of 13 Feb 2024 | 186.22k | 0.62% |
Dimensional Fund Advisors LPas of 04 Apr 2024 | 177.17k | 0.59% |